CE认证
皮肤填充剂
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.
主要优势： Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
适应症与专业用途
主要适应症
- Moderate to severe nasolabial folds
专业用途
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
治疗部位
- Moderate to severe nasolabial folds.
适用患者
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
作用原理： Olidia 240
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 OLIDIA 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.
更多产品： PRP Life Science
诊所替代选择
胶原蛋白刺激剂
/ 最近浏览
继续浏览
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.
主要优势： Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
适应症与专业用途
主要适应症
- Moderate to severe nasolabial folds
专业用途
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
治疗部位
- Moderate to severe nasolabial folds.
适用患者
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
作用原理： Olidia 240
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 OLIDIA 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.
更多产品： PRP Life Science
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。